essentially descending order of importance, these drugs and druggable targets may be
classified as follows:
- Proteins, peptides, amino acids
Enzyme proteins
a. As drugs
Alteplase (for ischemic stroke)
Retavase, tenecteplase (for acute myocardial infarction)
b. As druggable targets
Classical enzyme targets (acetylcholinesterase, monoamine oxidase)
Emerging targets (kinases, caspases)
Non-enzyme proteins
a. As drugs
Insulin, growth hormone
b. As druggable targets
Protein folding disorders (β-amyloid, prions) - Nucleic acids, nucleotides, nucleosides
a. As drugs
Antimetabolites
Antisense oligonucleotides
b. As druggable targets
Traditional antineoplastic/antiviral agents targeting nuclear DNA
Agents targeting ribozymes and RNA targets - Lipids
a. As drugs
Steroids (estrogens, progestins, androgens, corticosteroids)
Terpenes (pheromones)
b. As druggable targets
Anti-prostaglandin agents (cyclooxygenase inhibitors)
Anti-leukotriene agents (5-lipoxygenase inhibitors)
482 MEDICINAL CHEMISTRY
Figure 8.5 Macromolecular targets for drug design. The mammalian cell contains numerous
macromolecules including lipids, enzymatic proteins, non-enzymatic proteins, carbohydrates,
nucleic acids, other heterocycles, and water. All of these molecules present important opportunities
for drug design.